Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
5.42
+0.13 (2.46%)
Jan 29, 2026, 4:00 PM EST - Market closed
Alvotech Market Cap
Alvotech has a market cap or net worth of $1.7 billion as of January 29, 2026. Its market cap has decreased by -57.45% in one year.
Market Cap
1.70B
Enterprise Value
2.94B
1-Year Change
-57.45%
Ranking
Category
Stock Price
$5.42
Market Cap Chart
Since November 9, 2020, Alvotech's market cap has increased from $304.69M to $1.70B, an increase of 456.82%. That is a compound annual growth rate of 38.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 1.66B | 3.12% |
| Dec 31, 2025 | 1.61B | -59.76% |
| Dec 31, 2024 | 3.99B | 30.92% |
| Dec 29, 2023 | 3.05B | 22.59% |
| Dec 30, 2022 | 2.49B | 705.34% |
| Dec 31, 2021 | 308.75M | -5.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bausch Health Companies | 2.12B |
| Avadel Pharmaceuticals | 2.12B |
| Perrigo Company | 1.92B |
| Dynavax Technologies | 1.76B |
| ANI Pharmaceuticals | 1.68B |
| Amylyx Pharmaceuticals | 1.67B |
| Phibro Animal Health | 1.61B |
| Harrow | 1.59B |